Heart failure (HF) treatment has changed substantially over the last 30 years, leading to
significant reductions in mortality and hospital admissions in patients with HF with reduced …

Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …

A significant proportion of patients experience delays in the diagnosis of heart failure due to
the non‐specific signs and symptoms of the syndrome. Diagnostic tools such as …

Aim Patients with heart failure (HF) often suffer from a range of comorbidities, which may
affect their health status. The aim of this study was to assess the impact of different …

Aim Chronic obstructive pulmonary disease (COPD) is common in heart failure with a mildly
reduced or preserved ejection fraction (HFmrEF/HFpEF) and is associated with worse …

Background Little is known about the impact of chronic obstructive pulmonary disease
(COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and …

Beta (β)-blockers (BB) are useful in reducing morbidity and mortality in patients with heart
failure (HF) and concomitant chronic obstructive pulmonary disease (COPD). Nevertheless …

Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are common causes
of breathlessness which frequently co-exist; one potentially exacerbating the other …

Background Registries of patients hospitalized with acute heart failure (AHF) provided useful
description of characteristics and outcomes. However, a contemporary registry which …